Patients now living insulin free and off dialysis
Due to refined surgical techniques and advances in anti-rejection therapy, transplant surgeons at the University of Pittsburgh’s Thomas E. Starzl Transplantation Institute (STI) are able to successfully perform a higher volume of kidney-pancreas transplants – more than 22 kidney-pancreas transplants in the past three months – which yields a shorter wait time on the transplant list, a better graft survival and quicker recovery. "People need to be more aware of our services, in particular, diabetic patients with end-stage renal disease," said Ngoc Thai, M.D., Ph.D., assistant professor of surgery and director of pancreas transplantation at STI.
Another advance in the field of kidney-pancreas transplantation is the use of the drug campath – a powerful immunosuppressant that depletes T and B cells – the cells that may cause rejection of the new organ. Only one dose is given before the transplant surgery. Because of its potency, a single dose of campath can be given to treat active rejection as well. There is little risk above and beyond the usual side-effects of immunosuppression. The advantage is that patients only need to take the anti-rejection medication FK after surgery, as opposed to a combination of FK, MMF and steroids. Currently, researchers at STI are one of a few transplant centers in the United States participating in a clinical trial to study the advantages of campath therapy for kidney-pancreas transplant recipients.
Maureen McGaffin | EurekAlert!
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences